07 Jan 2001

Estragest TTS® (Estragest TTS® Transdermales Pflaster) - Deutschland

Updated: 07 Jan 2001

Estragest TTS®

Behandl. v. Beschwerden u. Symptomen des Östrogenmangels wie z. B. Hitzewallungen, Schlafstörungen, Urogenitalatrophie u. begleitende depress. Verstimmungen. Estragest TTS wird eingesetzt bei Pat. m. intaktem Uterus, die mind. 2 J. postmenopausal sind.

Estragest TTS® Description, Presentation and Dosage

Estragest TTS® Description

Estragest TTS® Drug Class Description

Östrogene u. Gestagene ohne andere Stoffe

Estragest TTS® Drug Description

1 Transdermales Pflaster enth.: Estradiol ½H2O 5,17 mg (entspr. 5 mg Estradiol), (nominelle Estradiol-Abgaberate 25 µg/Tag), Norethisteronacetat 15 mg (nominelle Norethisteronacetat-Abgaberate 125 µg/Tag), Abgabefläche 10 cm2.

Estragest TTS® Generic Name

Estragest TTS® Transdermales Pflaster

Estragest TTS® Presentation

Estragest TTS® Presentation

Estragest TTS®

Estragest TTS® Manufacturer

Novartis Pharma

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

CSU Knowledge Centre

CSU Knowledge Centre

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In this resource, you will find a disease overview, symposia highlights platform, video channel and additional resources including an events calendar and useful external links.

Estragest TTS® Dosage

Estragest TTS® Adult Dosage

Ethanol, Hydroxypropylcellulose, Pegoterat, Poly-(ethylen-co-vinylacetat), flüssiges Paraffin, Polyisobutylen, Silikonbeschichtung auf der Innenseite der Schutzfolie (wird vor Anw. des Pflasters entfernt).

Estragest TTS® Precautions, Reactions and Contraindications

Estragest TTS® Special Precautions

Estragest TTS® Special Precautions

G 5 a, f, O 6 a, b. Porphyrie. Aktive tiefe Venenthrombose od. thromboembol. Erkrank. (auch in der Anamnese).

Estragest TTS® Adverse Reactions

Estragest TTS® Adverse Reactions

Kontraind..

Related Drugs - Sexual Health

Back to top